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Abstract
In mycobacteria, D-alanine is an essential precursor for peptidoglycan biosynthesis. The only 
confirmed enzymatic pathway to form D-alanine is through the racemization of L-alanine by 
alanine racemase (Alr, EC 5.1.1.1). Nevertheless, the essentiality of Alr in Mycobacterium 
tuberculosis and Mycobacterium smegmatis for cell survivability in the absence of D-alanine has 
been a point of controversy with contradictory results reported in the literature. To address this 
issue, we examined the effects of alr inactivation on the cellular metabolism of M. smegmatis. The 
M. smegmatis alr insertion mutant TAM23 exhibited essentially identical growth to wild type 
mc2155 in the absence of D-alanine. NMR metabolomics revealed drastically distinct phenotypes 
between mc2155 and TAM23. A metabolic switch was observed for TAM23 as a function of 
supplemented D-alanine. In the absence of D-alanine, the metabolic response directed carbon 
through an unidentified transaminase to provide the essential D-alanine required for survival. The 
process is reversed when D-alanine is available, in which the D-alanine is directed to 
peptidoglycan biosynthesis. Our results provide further support for the hypothesis that Alr is not 
an essential function of M. smegmatis, and that specific Alr inhibitors will have no bactericidal 
action.
*Corresponding authors: Robert Powers, Department of Chemistry, School of Veterinary Medicine and Biomedical Sciences, 722 
Hamilton Hall, University of Nebraska-Lincoln, NE 68588-0304, Tel: (402) 472-3039, Fax (402) 472-9402, rpowers3@unl.edu, Raúl 
G. Barletta, School of Veterinary Medicine and Biomedical Sciences, 211 VBS, University of Nebraska-Lincoln, Lincoln, NE 
68583-0905, Tel. (402) 472-8543, Fax (402) 472-9690, rbarletta@unl.edu.
†Equal contribution
Author Contributions
R. G. B. and R. P. designed the research; S. H. performed NMR experiments and statistical analysis, D. D. M. performed statistical 
analysis, H. K. C., R. J. F., G. R., and D. K. Z. prepared and analyzed the growth of the M. smegmatis cultures; S. H., D. D. M. and R. 
P. analyzed NMR and statistical data; S. H., D. D. M., D. K. Z., R. G. B. and R. P. analyzed metabolomics data; K. K., R. J. F 
generated proteomics data, K. K., R. J. F. and R. G. B. analyzed proteomics data, S. H., D. D. M., D. K. Z., R. G. B. and R. P. wrote 
the paper.
ASSOCIATED CONTENT
Supporting information
The Supporting Information is available free of charge on the ACS Publications website at DOI:
The authors declare no competing financial interest.
HHS Public Access
Author manuscript
J Proteome Res. Author manuscript; available in PMC 2019 June 30.
Published in final edited form as:
J Proteome Res. 2017 March 03; 16(3): 1270–1279. doi:10.1021/acs.jproteome.6b00871.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
Graphical Abstract
Keywords
NMR metabolomics; Mycobacterium smegmatis; Mycobacterium tuberculosis; Alanine racemase; 
D-alanine biosynthesis
INTRODUCTION
Tuberculosis (TB) is a major global health problem and it remains the first worldwide cause 
of death from an infectious disease.1 Critical challenges to achieving the worldwide goals of 
disease control and elimination include the appearance of multiple and extensively drug 
resistant Mycobacterium tuberculosis strains, synergism with HIV driving co-infections in 
AIDS patients, and bacillary persistence in latently infected individuals.2 The cell wall of M. 
tuberculosis plays an important role in pathogenesis and its biosynthesis is a major source of 
targets for the design of antimicrobial agents and attenuated mutants.3–5 As in other 
eubacteria, peptidoglycan is a critical component of the cell wall backbone. D-alanine is an 
essential building block of peptidoglycan and is required for the formation of peptidoglycan 
crosslinks necessary to preserve cell integrity.3, 5–9
The main source of D-alanine in eubacteria is its conversion from L-alanine by alanine 
racemase (Alr), an enzyme encoded by the alr gene.3, 5, 8 The critical role of D-alanine in 
cell wall peptidoglycan biosynthesis has identified the biosynthesis of D-alanine as an 
important target for the generation of new anti-tuberculosis drugs. Also, attenuated mutants 
devoid of D-alanine biosynthesis are a potential source for vaccine candidates. Thus, alr 
essentiality and its role in mycobacterial physiology is core to the therapeutic value of 
targeting D-alanine biosynthesis. Studies on alr in the fast growing species Mycobacterium 
smegmatis, a useful model system for M. tuberculosis, rendered apparently contradictory 
results. In our initial reports, we found that the M. smegmatis alr insertion mutant grew 
without D-alanine.10–13 This data supported the existence of an alternative pathway of D-
alanine biosynthesis in mycobacteria. However, contradictory results were reported as M. 
smegmatis and M. tuberculosis alr deletion mutants were unable to grow without D-alanine 
supplementation.14, 15 These results negate the existence of an alternative endogenous 
pathway of D-alanine biosynthesis in both M. smegmatis and M. tuberculosis. In effect, D-
alanine provided by Alr, or an external source, were reported to be an absolute requirement 
for the growth of M. smegmatis and M. tuberculosis. A rational for the observed difference 
in the essentiality of M. smegmatis alr was attributed to the deletion mutant being a superior 
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construct to the insertion mutant. This explanation was based on an inferred residual Alr 
activity despite evidence to the contrary.10–13 Furthermore, the argument ignores the fact 
that the insertion mutant was generated by the insertion of a drug marker that split alr 
approximately in the middle of the gene,11 a procedure similar to the creation of null mutant 
strains by transposon mutagenesis.16 Importantly, the deletion and insertion mutants were 
also selected and tested under different culture conditions that may impact D-alanine 
auxotrophy. Moreover, our recent studies on the mechanism of action of D-cycloserine 
(DCS) in both M. smegmatis and M. tuberculosis support our prior conclusions that Alr is 
non-essential and that D-alanine ligase is the lethal target of DCS in both mycobacterial 
species.10–13
Resolution of the controversy surrounding alr conditional essentiality in mycobacteria is 
important, not only in the context of the role of Alr, but also for its implications in the design 
of more effective drugs and vaccines targeting the endogenous synthesis of D-alanine in M. 
tuberculosis. Additionally, evidence of horizontal gene transfer in mycobacteria,17, 18 
highlights the impact that the potential transfer of genes involved in an alternative pathway 
of D-alanine biosynthesis in a non-pathogenic species such as M. smegmatis might have on 
TB epidemiology and management. To address this issue, we undertook an NMR 
metabolomics study to determine whether D-alanine could be exchanged into the metabolic 
pool of the M. smegmatis alr insertion mutant TAM23. We report conclusive evidence for 
this exchange that suggest an alternative pathway of D-alanine biosynthesis in M. 
smegmatis.
MATERIALS AND METHODS
Bacterial strains and culture conditions.
Bacterial strains used in this study were M. smegmatis wild type mc215519 and alr mutant 
TAM23.11 For all experiments, strains were grown to an OD600 of 0.6 – 1.0 at 37 °C with 
shaking at 200 rpm in Middlebrook 7H9 complete media (MADC) supplemented with 0.2% 
(v/v) glycerol, 0.05% Tween 80, 0.01% cycloheximide, and ADC (0.5% bovine serum 
albumin (BSA) fraction V, 0.01 M glucose, and 0.015 M NaCl). Cycloheximide is a protein 
synthesis inhibitor, which was used to suppress the growth of yeast in the bacterial cell 
cultures. When necessary, cultures were supplemented with 50 mM D-alanine. For growth 
curve analysis, all cultures were inoculated to a starting OD600 of approximately 0.01 and 
the generation times were determined as previously described.20
Proteomics sample preparation and data collection.
All mc2155 and TAM23 cultures (50 mL) were grown to an OD600 of 0.8 – 1.1 in MADC 
media without D-alanine. The bacteria were removed, stored on ice for 10 min, and 
centrifuged at 3000 rpm at 4 °C for 15 min. The supernatant was removed from the cell 
pellet, filtered, and placed at −80 °C. Two washes with 30 mL ddH2O were performed, and 
the pellet was resuspended for a final volume of 1.0 mL in 50 mM ammonium bicarbonate 
containing 8 M urea and 1.5 mM phenyl-methyl-sulfonyl fluoride as a protease inhibitor. 
Cell lysis in the MP Biomedicals FastPrep-24 was performed 3 times for 20 s with a 5 min 
chill period between cycles. Two cycles of centrifugation were performed to remove cell 
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debris. Protein (0.5 – 1 mg) was precipitated with cold acetone. Samples were vortexed and 
incubated overnight at −20 °C. Samples were then warmed to room temperature, pelleted by 
centrifugation at 14000g for 20 min, and the supernatant was discarded. After air-drying for 
15 – 30 min, samples were subjected to MudPIT analysis at the University of Nebraska-
Lincoln (UNL) Redox Biology Center Proteomics and Metabolomics Core Facility. A 
protease and trypsin digest was performed on the protein mixtures and then subjected to 
liquid chromatography electrospray mass spectrometry LC-ESI-MS. Protein identification 
was performed by a Mascot database search.21
NMR metabolomics sample preparation.
General procedures for the handling and preparation of M. smegmatis NMR samples for 
metabolomics analysis have been described elsewhere.22 Metabolomics samples for one-
dimensional (1D) 1H NMR experiments were prepared from ten replicates of both M. 
smegmatis mc2155 and TAM23 cell cultures. M. smegmatis mc2155 and TAM23 strains 
were grown at 37 °C with shaking at 200 rpm in 50 mL of MADC media in 250 mL flask 
for 10 – 12 hours until an OD600 of 0.6 – 1.0. A second set of ten replicate cultures per strain 
were grown under the same condition with the exception that the TAM23 cultures were 
supplemented with 50 mM D-alanine after the OD600 reached approximately 0.6. All of the 
bacterial cultures were then allowed to grow for an additional 2 h. The cell cultures were 
placed on ice for 5 min and kept on ice throughout the entire process of metabolome 
extraction. Bacterial cells were harvested by centrifugation at 2000g at 4 °C for 15 min in 50 
mL tubes. The cells were washed twice with 30 mL of ice-cold double distilled water. The 
cell pellets were re-suspended with 1.0 mL of double distilled water and transferred to a 2 
mL vial containing 0.1 mm silica beads (Lysing Matrix B). The cells were then lysed for 40 
s at 6 m/s using a MP Biomedicals FastPrep-24. The cell lysate was centrifuged for 10 min 
at 12 400g and 4 °C. The supernatant was extracted and then lyophilized and resuspended 
with 1.0 mL of 100% D2O containing 50 mM phosphate buffer (uncorrected pH = 7.2) with 
50 µM 3-(trimethylsilyl) propionic-2,2,3,3-d4 acid sodium salt (TMSP). The samples were 
vortexed and then centrifuged. A 600 µL portion of the cell free extract was then transferred 
to an NMR tube. A total of 40 metabolomics samples were prepared for collecting one-
dimensional (1D) 1H NMR spectra.
NMR metabolomics samples for two-dimensional (2D) 1H-13C HSQC experiments were 
prepared from triplicate M. smegmatis mc2155 and TAM23 cultures grown in 110 mL 
MADC media (250 mL flasks). The bacterial cultures were grown at 37 °C with shaking at 
200 rpm for 10 – 12 h until an OD600 of approximately 0.6. The culture media was then 
supplemented with or without 100 μM [13C2]-D-alanine and the cultures were allowed to 
grow for an additional 2 h. The bacterial cells were processed and the metabolome was 
extracted following the same protocol described above.
NMR data collection.
The NMR data was collected and processed according to our previously described protocol.
23 The NMR spectra were collected on a Bruker Avance DRX 500 MHz spectrometer 
equipped with a 5 mm triple-resonance cryogenic probe (1H, 13C, 15N) with a z-axis 
gradient, BACS-120 sample changer, and an automatic tuning and matching accessory was 
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utilized for automated NMR data collection. 1D 1H NMR spectra were collected with Purge 
solvent saturation,24 a 1H 90° pulse of 8 μs, and a spectral width of 5482.5 Hz and 32k data 
points at 298 K. A total of 16 dummy scans and 128 scans were used with a recycle delay of 
1.5 s for a total acquisition time of 10 minutes per spectrum.
A series of three time-zero 2D 1H-13C HSQC spectra (HSQC0) were collected using the 
pulse sequence described by Hu et al. for determination of absolute metabolite concentration 
changes.25, 26 The NMR spectra were collected with 2048 data points and a spectral width of 
5000.0 Hz in the direct 1H dimension, and 64 data points and a spectral width of 17605.6 Hz 
in the indirect 13C dimension. A total of 16 dummy scans and 64 scans with a relaxation 
delay of 1.5 s were used to obtain each 2D 1H-13C HSQC0 spectrum with a total acquisition 
time of 6 hours.
Multivariate statistical analysis.
The 1D 1H NMR spectra were processed in our MVAPACK software suite (http://
bionmr.unl.edu/mvapack.php).27 For principal component analysis (PCA), the 1D 1H NMR 
spectra were processed with a 1.0 Hz exponential apodization function, followed by Fourier 
transformation, automatic phasing and normalization with phase-scatter correction (PSC),28 
and referenced to TMSP-D4 (0.0 ppm). The noise and solvent containing regions were 
manually removed, the spectrum was binned using an adaptive intelligent binning algorithm,
29 and Pareto scaled. For orthogonal projections to latent structures discriminant analysis 
(OPLS-DA), the NMR data was processed using MVAPACK as described above. The table 
of integrals was center averaged and imported into SIMCA version 13.0 (Umetrics) to 
produce the S-plots. Supervised classification for each group was determined by cell type, 
with M. smegmatis mc2155 defined as the control (or assigned a value of 0) and M. 
smegmatis TAM23 was assigned a value of 1. Ellipses were generated for each group in the 
PCA scores plot using our PCA/PLS-DA utilities.30, 31 The ellipses correspond to the 95% 
confidence limits of a normal distribution for each group.
Metabolite identification and measurement of absolute concentration changes.
2D 1H-13C HSQC spectra were processed using NMRPipe.32 The spectra were Fourier 
transformed, manually phased, and baseline corrected. The processed 2D 1H-13C HSQC 
spectra were then analyzed using NMRView33 to assign chemical shifts, intensities, and 
volumes to each NMR resonance. Chemical shift lists were assigned to specific metabolites 
using the Human Metabolome Database,34 Madison Metabolomics Database,35 and the 
Platform for Riken Metabolomics.36 A chemical shift error-tolerance of 0.05 ppm and 0.40 
ppm was used for 1H and 13C chemical shifts, respectively. The identification of metabolites 
and metabolomics pathways from the NMR metabolomics data were further verified using 
the Kyoto Encyclopedia of Genes and Genomes (KEGG)37 and MetaCyc38 databases.
Metabolite peak volumes from the HSQC0 experiment was calculated as previously 
described.25, 26 Briefly, peak volumes from a 2D 1H-13C HSQC experiment are dependent 
on the magnitude of J-coupling constants, relaxation processes, dynamics, and metabolite 
concentrations. The HSQC0 experiment is a series of three HSQC experiments with an 
increasing number of HSQC pulse sequence repetitions (i.e., HSQC1, HSQC2, HSQC3). In 
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this manner, the HSQC peak volume will decrease proportional to the number of pulse 
sequence repetitions due to the impact of all factors except concentration. A natural log plot 
of peak volumes versus the increment number (1, 2, 3) allows for the extrapolation back to 
increment 0 or zero-time, which is proportional to the metabolite’s concentration. The 
calibration of metabolite peak volumes from the HSQC0 experiments with an absolute 
concentration was calculated with a standard calibration curve as previously described.23 
Briefly, five different mixtures containing nine different 13C-labeled metabolites (2-keto-3-
methylbutyrate, 2-ketobutyrate, acetate, alanine, fructose, glucose, glycine, pyruvate, 
succinate) with a range of known concentrations (5 to 300 μM) were used to collect a series 
of HSQC0 experiments. The HSQC0 peak volumes were determined for each metabolite at 
each concentration as described above. The HSQC0 peak volumes were then plotted versus 
the known metabolite concentrations to yield a standard calibration curve. The triplicate 
HSQC0 experiments were used to calculate averages and standard deviations for each 
metabolite concentration.
RESULTS
Growth curves of M. smegmatis alr mutants.
When grown in MADC, the wild type and the alr insertion mutant were still able to 
proliferate in the absence of D-alanine. In our original studies, we observed that TAM23 
grew with a significant lag time when subcultured from an inoculum grown in media with 
D-alanine. However, in this study we subcultured from inocula prepared after the cells were 
passaged in media without D-alanine. Under these conditions, both strains yielded growth 
curves that followed similar trends (Fig. 1A). Strains mc2155 and TAM23 grew with a 
generation time of 208 ± 34 and 294 ± 29 min, had an initial lag phase of 5 and 12 h, and 
reached saturation densities (OD600) of 2.5 and 2.1, respectively. A similar result was 
obtained for both strains when the media was supplemented with D-alanine except for a 
moderately higher saturation density for TAM23 (Fig. 1B). Strains mc2155 and TAM23 had 
generation times of 310 ± 28 and 294 ± 33 min, lag phases of 4 and 6.5 h, and saturation 
densities of 1.7 and 2.54, respectively. When comparing the growth curves with and without 
D-alanine, TAM23 was able to grow more efficiently in the presence of D-alanine while the 
opposite was true for mc2155. Even though the slopes during the exponential phase of 
growth are significantly different (p-value < 0.001) when comparing TAM23 grown in no D-
alanine to mc2155 grown with and without D-alanine, and TAM23 with D-alanine; there 
does not appear to be a biological difference. These results demonstrate that the alr gene is 
not essential for the survivability of M. smegmatis in the absence of D-alanine and that an 
alternative pathway for synthesizing D-alanine must exist.
Major proteomic changes in M. smegmatis alr mutants.
MudPIT analysis identified 904 proteins expressed in media without D-alanine. TAM23 
protein overexpression was defined as a 10-fold or greater expression level relative to 
mc2155. Thirty-one proteins were identified as being overexpressed in TAM23 relative to 
mc2155 (Supplemental Table S1). Several enzymes directly involved in central carbon 
metabolism were affected by the alr mutation. Specifically, alanine dehydrogenase (ALD), 
and several alcohol dehydrogenases (ADHs), were all overexpressed in TAM23. The ADH 
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enzymes exhibited an approximate 40-fold increase in TAM23 relative to mc2155. Similarly, 
ALD was upregulated by approximately 30-fold in TAM23.
Metabolic impact of media lacking D-alanine on M. smegmatis alr mutants.
The set of 1D 1H NMR spectra were used to assess the global metabolome differences 
between wild type M. smegmatis mc2155 and the alanine racemase TAM23 insertion mutant 
(Fig. S1). The PCA scores plot (Fig. 2A) compares the metabolomes of M. smegmatis 
mc2155 cells and the TAM23 insertion mutant grown in MADC without D-alanine. The 
scores plot reduces the complex 1D 1H NMR spectrum that captures the state of the cellular 
metabolome into a single point in principal component space (PC1, PC2, etc.). 
Correspondingly, the principal components represent the largest variations between the 
individual 1D 1H NMR spectra. The scores plot indicates that PC1 and PC2 account for 
51.0% and 21.0% of the variation in the NMR spectra, respectively. A total of 10 replicates 
for the wild type mc2155 and the alr TAM23 insertion mutant form two distinct clusters in 
the PCA scores plot. The unsupervised PCA model demonstrates a statistically significant 
difference between the metabolomes of M. smegmatis wild type mc2155 cells and the alr 
TAM23 insertion mutant.
An OPLS-DA model was generated from the metabolomics datasets to further characterize 
the mc2155 and TAM23 metabolome and to identify the discriminatory variations that 
maximize group separation.39 The OPLS-DA model without the addition of D-alanine 
yielded a reliable fit as evident by an R2X of 0.652, R2Y of 0.971, and a Q2 of 0.923 (Fig. 
S2A). Importantly, cross validation using CV-ANOVA produced a statistically significant p 
value of 5.17 × 10−6 indicating a valid OPLS-DA model. The group separation between the 
alanine racemase TAM23 mutant and the mc2155 wild type metabolomes is statistically 
significant, which is consistent with the group separation observed in the PCA scores plot. 
Furthermore, an S-plot generated from the OPLS-DA model identified the NMR spectral 
differences and, correspondingly, the major metabolome changes contributing to the group 
separations in the scores plot (Fig. 2B). The variables (chemical shifts) with a large 
modelled correlation [approximately 1 (correlated) or −1 (anticorrelated)] and large modeled 
co-variation ≥ 0.1 or ≤ −0.1 were identified as key contributors to group separations in the 
OPLS scores plot and are labeled on the S-plot. The metabolites from the S-plot identified as 
major contributors to group separation in the absence of supplemental D-alanine are 
summarized in Table 1.
Impact of D-alanine on the metabolome of M. smegmatis alr mutants.
The NMR metabolomics experiment was repeated using M. smegmatis mc2155 and TAM23 
cells grown in MADC supplemented with 50 mM D-alanine. As observed previously, the 
PCA scores plot contained two distinct clusters indicating a difference between the mc2155 
and TAM23 metabolomes (Fig. 2C). PC1 and PC2 account for 68.5% and 13.7% of the 
variation in the data, respectively.
The OPLS-DA scores plot exhibited a similar group separation between M. smegmatis 
mc2155 wild type cells and the TAM23 alr mutant (Fig. S2B). The OPLS-DA yielded a 
reliable fit as evident by R2X of 0.682, R2Y of 0.981 and a Q2 of 0.957. Importantly, cross 
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validation using CV-ANOVA produced a statistically significant p value of 4.39 × 10−10 
indicating a valid OPLS-DA model. The group separation between the alanine racemase 
TAM23 mutant and the mc2155 wild type metabolomes is statistically significant, which is 
consistent with the group separation observed in the PCA scores plot. The S-plot from 
OPLS-DA model was used to identify the chemical shifts (metabolites) that significantly 
contributed to the group separation in the OPLS-DA scores plot (Fig. 2D). The metabolites 
from the S-plot identified as major contributors to group separation in the presence of 
supplemental D-alanine are summarized in Table 1.
Quantitative analysis of metabolite changes in M. smegmatis alr mutants.
The NMR metabolomics experiment was repeated using M. smegmatis mc2155 and TAM23 
cells grown in MADC supplemented with 100 µM of 13C-labeled [13C2]-D-alanine. 
Triplicate sets of 13C-labeled metabolite extracts were prepared per strain and then analyzed 
using time-zero 1H-13C HSQC (HSQC0) experiments.25, 26 A 2D 1H-13C HSQC NMR 
spectrum allows for easier identification of metabolites because of the reduced complexity 
and spectral overlap compared to a 1D 1H NMR spectrum. Only metabolites that originate 
from the supplemental 13C-D-alanine are observed in the 2D 1H-13C HSQC spectrum (Fig. 
S3). Each peak in the 2D 1H-13C represents a 13C-1H pair for a specific metabolite that were 
assigned by matching the chemical shifts against NMR metabolomics databases.34–36 A 
total of 38 metabolites were identified from the two M. smegmatis strains.
A concentration for each metabolite was determined by extrapolating peak volumes from a 
series of three 2D 1H-13C HSQC spectra at different time points to interpolate a time-zero 
peak volume. The spectra were collected in triplicate to determine an average peak volume 
and calculate a standard deviation. The average time-zero peak volume is directly 
proportional to a concentration based on a calibration curve using 9 13C-labeled compounds 
of known concentration.23 A plot of the absolute metabolite concentrations for the M. 
smegmatis mc2155 and TAM23 strains is shown in Fig. 3. Peptidoglycan precursors such as 
glutamate, lysine, and N-acetyl-glucosamine were significantly decreased in the alr insertion 
mutant. The concentration of trehalose, an essential precursor for trehalose-containing 
glycolipids, which allows the attachment of glycolipids to arabinogalactan in the cell wall 
was also decreased in the alr insertion mutant.40
DISCUSSION
Multiple resistant strains of TB are growing and spreading at a rapid pace; and the 
concurrent loss of antibiotic efficacy is predicted to cause upwards of 10 million deaths 
annually by 2050. Avoiding this potential pandemic requires developing new antibiotics that 
circumvent common mechanisms of resistance, which necessitates the identification of novel 
therapeutic targets. For antibiotics, therapeutic targets have commonly been an essential 
enzyme or protein. Alr is a pyridoxal 5’-phosphate (PLP) - containing enzyme which is 
thought to be necessary for the growth of mycobacteria.41–43 The racemization of L-alanine 
to D-alanine by Alr is the only confirmed enzymatic reaction in M. tuberculosis or M. 
smegmatis to produce the D form of alanine, which is an essential intermediate for 
peptidoglycan biosynthesis.8 Nevertheless, the essentiality of Alr in M. smegmatis and M. 
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tuberculosis survivability and its significance as a therapeutic target have been highly 
controversial.
Chacon et al. previously observed that an alr knock-out mutant (TAM23) was able to grow 
under conditions without supplementing D-alanine into Middlebrook 7H9 or minimal 
medium.10, 11 The TAM23 strain did not exhibit any growth defects, but it was clear that the 
phenotypic changes between TAM23 and the wild type strain were pronounced.10, 11 Again, 
we did not observe any biologically significant differences when we compared the TAM23 
growth curve, upon passage for growth in media without D-alanine, to the wild type mc2155 
strain in the absence of D-alanine (Fig. 1A). In fact, we observed a higher saturation density 
for the TAM23 growth curve relative to mc2155 with the addition of D-alanine to the culture 
media (Fig. 1B). One potential interpretation is that the stress response TAM23 experiences 
due to the lack of both alr activity and D-alanine is partly relieved by supplemented D-
alanine leading to a relative improvement in cell growth. Regardless, TAM23 does not 
exhibit any growth defects in the absence or presence of D-alanine strongly implying that 
the alr inactivation does not negatively impact cell survivability. This is in direct conflict 
with other studies that show Alr to be essential in mycobacteria.14, 15 These discrepancies 
may be attributed to contrasting mutant construction and cell growth conditions. TAM23 is 
an insertion mutant which still has the potential of producing a protein product with residual 
or defective activity. However, as discussed above, this possibility is extremely unlikely as 
the insertion mutation would be similar to a transposon insertion in the middle of the gene. 
Furthermore, we previously examined Alr activity in TAM23 and did not detect any activity 
above BSA background (Fig. 1C).10 The lack of Alr activity in TAM23 was also supported 
by examining the steady state concentrations of L- and D -alanine. L-alanine was observed 
to accumulate in TAM23, which is consistent with an inactive Alr (Fig. 1D). Conversely, the 
D-alanine production in TAM23 was below that of mc2155, but still above background 
levels. This is consistent with the alr mutant producing D-alanine through an alternative 
mechanism. Recently, we proposed an alternative metabolic pathway for the production of 
D-alanine in M. tuberculosis and M. smegmatis to compensate for an inactive Alr.12, 13 An 
alternative source of D-alanine may result from an unidentified transaminase converting 
pyruvate into D-alanine. This hypothesis resulted from a metabolomics investigation into the 
in vivo lethal target of DCS, in which Alr and D-alanine-D-alanine ligase (Ddl) had been 
previously identified as likely targets for DCS. We identified Ddl as the in vivo lethal target 
of DCS based on an observed decrease in the biosynthesis of D-alanyl-D-alanine that 
occurred simultaneously with a DCS induced inhibition on cell growth. We also previously 
observed the incorporation of 13C-carbons from D-alanine into glutamate was dependent on 
DCS concentration, which strongly suggests a transaminase compensating for an inactive 
Alr.
Herein, we further tested our hypothesis that Alr is nonessential for peptidoglycan 
biosynthesis and the survivability of M. smegmatis by examining the total proteomic and 
metabolic shifts that occurs in TAM23 relative to wild type mc2155 cells. Our proteomics 
analysis revealed that ALD and ADH enzymes were significantly overexpressed from Alr 
inactivation. Of particular note, ALD is involved in a metabolic recycling process, which 
includes an alternative pathway for the biosynthesis of D-alanine. ALD catalyzes the 
oxidative deamination of L-alanine to produce pyruvate and ammonia with concomitant 
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formation of NADH.44 Thus, ALD may provide an alternative source of D-alanine via 
pyruvate, where pyruvate and D-glutamate are then converted into D-alanine and α-
ketoglutarate by a transamination reaction. A D-amino acid aminotransferase (Dat) capable 
of catalyzing this transamination reaction has been previously observed in Bacillus subtilis, 
Listeria monocytogenes, and numerous other bacteria.45–50 While not verified, we 
previously identified a number of enzymes that may potentially perform the same function in 
M. smegmatis.51 In the absence of supplemental D-alanine, the overproduction of ALD in 
TAM23 increases the reducing potential (generation of NADH). This is compensated by the 
overproduction of ADH enzymes to regenerate NAD through the oxidation of NADH. Thus, 
this metabolic change is necessary to maintain redox balance when Alr is inactive.
The increase in ammonia production from an elevated ALD activity did not lead to an 
observable toxicity for M. smegmatis. In fact, ammonia is a preferred source of nitrogen for 
M. smegmatis, and is a diffusible substance that participates in many metabolic processes 
and, consequently, is under tight regulatory control.52–54 There is always a balance of 
oxidative deaminations and reductive aminations. Further, there are outer membrane proteins 
that participate in the influx and efflux of ammonia. As a result, M. smegmatis is readily 
able to adapt to large variations in nitrogen (ammonia) availability through a variety of 
cellular processes. Similarly, the increase in ADH activity to regenerate NAD would be 
expected to increase the conversion of an acetaldehyde to an alcohol, which is then excreted 
from the cell. This is also consistent with the prior observation that M. smegmatis ADH has 
a preference to function as an aldehyde reductase and convert acetaldehydes into alcohols.55
From a 1D 1H NMR metabolomics study we observed statistically significant differences 
between the mc2155 and TAM23 metabolomes based on the distinct clusters in the PCA 
scores plot (Fig. 2A). The metabolite changes identified from the resulting S-plot (Fig. 2B) 
are listed in Table 1. As previously observed, the difference in the mc2155 and TAM23 
metabolomes was eliminated when TAM23 was complemented with the wild type alr gene.
12 Conversely, supplementing the culture media with D-alanine had no effect, the mc2155 
and TAM23 global metabolomes are still significantly different (Figs. 2C and 2D and Table 
1). The pronounced difference in the mc2155 and TAM23 metabolomes and the inability of 
supplemental D-alanine to reverse these metabolic differences eliminates the hypothesis that 
TAM23 is able to survive in the absence of D-alanine due to residual or defective Alr 
activity. Instead, the metabolic differences persist because a clear switch in the metabolic 
state of TAM23 ensues when TAM23 is cultured in the presence or absence of D-alanine. 
TAM23 cells enter an anabolic state when D-alanine is not readily available. Intriguingly, 
when D-alanine is available to TAM23, we observe a complete reversal in the flow of carbon 
through some metabolic processes. In effect, the addition of D-alanine circumvents the need 
for a metabolic response to replace the missing D-alanine due to the alr inactivation. Instead, 
TAM23 simply directs the D-alanine into peptidoglycan biosynthesis, which then allows the 
cell to pursue normal metabolic processes. Nevertheless, TAM23 still exhibits a distinct 
metabolism compared to mc2155. For instance, fatty acids are increased in TAM23 relative 
to mc2155, presumably to redirect fatty acids to increase cell wall integrity. The metabolites 
that exhibited a reversal in cellular concentrations based on the availability of D-alanine are 
colored in the metabolic pathways in Fig. 4. Indeed, supplementation with D-alanine 
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induced a metabolic switch for TAM23 as revealed by the 1D 1H NMR metabolomics 
experiments (Fig. 4B).
To further evaluate the metabolic response due to alr inactivation, we traced the distribution 
of 13C-carbon derived from [13C2]-D-alanine throughout the TAM23 and mc2155 
metabolome using 2D 1H-13C HSQC NMR experiments (Figs. 3 and 4A). In M. tuberculosis 
and M. smegmatis, D-alanine can be directly converted into L-alanine (by Alr), into D-
alanyl-D-alanine (by Ddl), into pyruvate (by an unidentified transaminase), or into alanyl-
poly(glycerolphosphate)/D-alanine--poly(phosphoribitol). As expected, alr inactivation 
causes more of the supplemented D-alanine to be biosynthesized into D-alanyl-D-alanine in 
TAM23 relative to mc2155. More notably, a drastic decline is observed in the conversion of 
D-alanine into glutamate and pyruvate along with an accumulation of [13C2]-D-alanine in 
TAM23. This is consistent with an inactive Alr in TAM23 that prevents the D-alanine carbon 
from entering into other metabolic pathways besides peptidoglycan biosynthesis. In fact, a 
likely pathway is the conversion of D-alanine into pyruvate by the unidentified transaminase, 
which, apparently, is significantly less efficient than Alr in directing the supplemental D-
alanine into central carbon metabolism. Conversely, the supplied D-alanine is not essential 
to peptidoglycan biosynthesis in mc2155 since Alr is still active. Instead, D-alanine can be 
used as an alternative carbon source by converting it into L-alanine, which is then diverted 
into other metabolic processes. We observed an increase in the conversion of [13C2]-D-
alanine into glucose, fructose-6-phosphatate, pyruvate, glutamate, GABA, succinate 
aspartate and citrulline for mc2155 (Figs. 3 and 4A). This indicates an increase in the flow of 
carbon through glycolysis, the TCA cycle and urea cycle with a simultaneous decrease from 
peptidoglycan biosynthesis. Notably, the 1D 1H NMR experiments indicate an increase in 
the cellular concentration of citrulline, glutamate, and succinate for TAM23 with 
supplemental D-alanine. This apparent discrepancy highlights the fact that the different 
NMR experiments actually measure two distinctly different metabolic changes. The 1D 1H 
NMR experiments measure the total pool of these metabolites within the cell culture 
regardless of the carbon source. Conversely, the 2D 1H-13C HSQC experiment is only 
measuring the amount of citrulline, glutamate, and succinate derived from the supplied 
[13C2]-D-alanine. The observed changes in the concentrations of GABA and glutamate for 
TAM23 may also be indicative of a stress response resulting from an inactive Alr in our 
mutant strain especially in conditions without D-alanine.55 The decrease in GABA and 
glutamate derived from [13C2]-D-alanine are consistent with D-alanine being shunted into 
other critically needed metabolites, where other carbon sources may be used for GABA and 
glutamate production.
CONCLUSION
Taken together, these new data uniformly agree with the hypothesis of an inactive Alr in 
TAM23 and an alternative transaminase as a source of D-alanine for TAM23 (Fig. 4). Our 
results further confirm that Alr is not an essential enzyme in M. smegmatis. Since central 
metabolic pathways are conserved in mycobacteria, these results also suggest that Alr is not 
essential in M. tuberculosis and that Alr inhibitors will not have a bactericidal action.
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Figure 1. 
Growth curves for wild-type M. smegmatis mc2155 cells (blue) or alr mutant TAM23 cells 
(red) treated (A) without D-alanine or (B) with 50 mM D-alanine, respectively. Growth 
curves were collected in triplicate and the error bars were calculated using SEM. (C) Mean 
specific activities (µmoles of substrate consumed per min per mg protein) in M. smegmatis 
cell extracts. Data are as described previously by Chacon et al. 2002.11 Cells were grown to 
mid-exponential phase, harvested, and lysed. Cell-free extracts were assayed for Alr activity 
in triplicate. A bovine serum albumin (BSA) control was prepared at the same protein 
concentration as the cell extracts and assayed in triplicate. All error bars were calculated 
using standard deviations. (D) Intracellular steady-state concentrations of amino acids L- 
and D- alanine in mc2155 (black) and TAM23 (grey). Data reproduced from Chacon et al. 
2009.10
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Figure 2. 
PCA scores plots generated from 1D 1H NMR spectra obtained from M. smegmatis TAM23 
(red) and mc2155 (blue) cell lysates (A) without or (C) with media supplemented with D-
alanine. OPLS-DA S-plots comparing the 1D 1H NMR spectra obtained from TAM23 and 
mc2155 cell lysates (B) without or (D) with media supplemented with D-alanine. Each point 
in the S-plot represents a specific bin of integrals for a chemical shift range of 0.25 ppm. 
The points at the extreme ends of the S-plots are major contributors to class distinction. The 
red points represent a decrease in the binned integrals for TAM23 compared to mc2155. The 
blue points represent an increase in the binned integrals for TAM23 compared to mc2155. 
Green points represent metabolites that are approximately equally in both strains. The 
labeled points were assigned to the following metabolites: 1) fatty acids, 2) ethanol, 3) 
glutamate, 4) oxaloacetate, 5) GABA, 6) succinate, 7) glycerol, 8) isoleucine, 9) valerate, 
10) lactate, 11) N-acetylglucosamine-6-phosphate, 12) α-ketoisovalerate, 13) glycolate, 14) 
serine, 15) phosphoserine, 16) threonine, 17) lysine, 18) alanine, 19) glucarate, 20) ATP, 21) 
unidentified (UD), 22) trehalose, 23) valine, 24) ornithine, 25) α-ketoglutarate and 26) 
citrulline.
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Figure 3. 
Bar graph summarizing metabolite concentrations determined from 2D 1H-13C HSQC0 
experiments. M. smegmatis mc2155 (blue) and TAM23 (red) cell cultures were 
supplemented with 100 µM 13C-labeled [13C2]-D-alanine. Statistical significance at the 95% 
confidence level is denoted by a black asterisk, and a red asterisk indicates a statistical 
significance after applying Bonferroni multiple hypothesis correction. (insert) Expanded 
view of an overlay of the wild type strain mc2155 (blue) and alr insertion mutant TAM23 
(red) 2D 1H-13C HSQC0 spectra highlighting alanine concentration changes. The full 
spectral overlay is in supporting information (see Fig. S3).
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Figure 4. 
(A) Metabolic network map displays the 2D 1H-13C-HSQC time zero absolute metabolite 
concentration differences between M. smegmatis wild type mc2155 and alr insertion mutant 
TAM23 grown in MADC media and treated at mid exponential phase with [13C2]-D-alanine. 
A positive blue bar indicates a concentration increase in mc2155 relative to TAM23. A 
negative red bar indicates a concentration decrease in mc2155 relative to TAM23. The 
plotted concentrations are on a µM scale and the error bars represent standard deviations. 
Metabolites highlighted in magenta exhibited a reversal in concentration depending on 
whether media were supplemented with or without D-alanine from the 1D 1H NMR 
experiments and Table 1. L-alanine dehydrogenase (ALD), highlighted in red, was 
overexpressed in TAM23 relative to mc2155. The dark arrows identify the primary carbon 
flux pathway, blue arrows represent a hypothetical pathway for D-alanine biosynthesis that 
is depicted in detail in (B), and the dotted lines represent established alternative routes. (B) 
Metabolic network summarizing the 1D 1H NMR data and the L-D amino acid pools (see 
Fig. 1D and Table 1) comparing mc2155 with TAM23 from cultures without supplemental 
D-alanine. Metabolites colored blue were observed to increase in mc2155 relative to 
TAM23. Diagram adapted from Halouska et al. 2014.51
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Table 1.
Relative differences in metabolite concentrations between M. smegmatis wild-type and TAM23 alr mutant 
cells
No D-alanine
a,b
50 mM D-alanine
Relative Increase Relative Decrease Relative Increase Relative Decrease
Alanine α-ketoisovalerate Citrulline Alanine
ATP Ethanol Fatty acid α-ketoglutarate
Fatty acid GABA Glutamate GABA
Glucarate Glutamate Isoleucine Lysine
Glycolate Glycerol Oxaloacetate Ornithine
Lysine Isoleucine Succinate Trehalose
Phosphoserine Lactate Threonine Valine
Serine N-acetyl-glucosamine-6-phosphate
Threonine Oxaloacetate
Succinate
Valerate
a
Observed increase or decrease in metabolite concentrations in M. smegmatis TAM23 alr mutant cells relative to wild type mc2155 cells. 
Metabolites were identified from the S-plots generated from the corresponding OPLS-DA model (see Fig. 2).
b
Metabolites in italics exhibited a reversal in concentration depending on whether media were supplemented with or without D-alanine.
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